ReviewQuantitative imaging in medicine and surgery2024
Progress of echocardiography in the evaluation of left atrial function in patients with heart failure with preserved ejection fraction: a narrative review.
Review in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of left atrial function in patients with severe aortic stenosis with preserved ejection fraction based on real-time three-dimensional automated left atrial quantification technique.Quantitative imaging in medicine and surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: About half of all heart failures are heart failures with preserved ejection fraction (HFpEFs). As the population ages and metabolic disorders become more common, the prevalence of HFpEF continues to increase annually. Patients with HFpEF typically show a decline in various reserve capacities after exercise. According to recent research, patients with HFpEF may have significant clinical symptoms due to left atrial (LA) dysfunction. Patients with HFpEF may benefit greatly from the early detection of LA myocardial damage using echocardiographic measurements, particularly LA strain. This article examined state-of-the-art echocardiography as it relates to the assessment of LA function in patients with HFpEF. Methods: Databases such as PubMed, Google Scholar, and Baidu Scholar were searched to retrieve the latest articles on research advances in the field from 1998 to 2024. The article searches were not limited by rigid language or publication date constraints. Key Content and Findings: This article outlines LA strain measurements using echocardiography, and provides the current normal reference range for LA strain values. Further, the features of differences in LA strain during exercise and rest are outlined for HFpEF patients in varying stages of heart failure. Finally, the clinical significance of LA strain in HFpEF is highlighted, including its substantial advantages in diagnosing diastolic dysfunction and left ventricular filling pressures, as well as its diagnostic and prognostic utility and potential as a therapeutic target. Conclusions: When evaluating the structure and function of the left atrium in patients with HFpEF, echocardiography shows a great deal of clinical promise. Specifically, LA strain may provide additional useful information for the early identification of LA dysfunction in HFpEF patients. The measurement of LA size is currently the only clinical test available for evaluating the left atrium in individuals with HFpEF. This review will enable ultrasonographers and physicians to better understand the clinical utility of LA strain in patients with HFpEF, and also provides important resources for future LA strain-related scientific research and clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.